# ANDAs: Impurities in Drug Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/andas-impurities-in-drug-products-guidance-for-industry/1729c807-7b92-415c-a307-05a491b55e63

> FDA guidance document: ANDAs: Impurities in Drug Products:  Guidance for Industry. Issue date: November 29, 2010. Get complete insights and analysis.

---

## Details

- Title: ANDAs: Impurities in Drug Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2010-11-29
- Last Changed: 2020-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0584">FDA-2010-D-0584</a>

## Related Documents

- [Abuse-Deterrent Opioids-Evaluation and Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/abuse-deterrent-opioids-evaluation-and-labeling/cd0f4ddf-e4fc-4694-a929-33733fb8e8db)
- [ANDAs: Impurities in Drug Substances:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/andas-impurities-in-drug-substances-guidance-for-industry/f8f33332-d6b5-44e6-a308-aa86ea6fa74f)
- [ANDAs: Stability Testing of Drug Substances and Products](https://www.globalkeysolutions.net/guidances/guidance-document/andas-stability-testing-of-drug-substances-and-products/c3403aba-7f4f-4aa1-9f7b-94ae55a3486f)